Natco Pharma gets CTPR launch approval from Delhi High Court

20 Sep 2022 Evaluate

Delhi High Court has allowed Natco Pharma to launch Chlorantraniliprole (CTPR) and its formulations, through its non-infringing process. CTPR technical is formulated into broad-spectrum insecticides used across wide range of crops for pest management. The company estimates the current market size of CTPR containing products in India to be over Rs 2000 crore. The Company plans to launch its products very shortly.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

895.90 -12.20 (-1.34%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×